With all of the recent expansion of sentinel lymph node mapping for melanoma and breast cancers and now in all solid tumors, some experts are wondering about the value of this technique for ovarian cancer. A study published ahead of print Oct. 20 in the Journal of Nuclear Medicine makes the case.

Surgery for gastroesophageal reflux disease (GERD) could be improved by an emerging imaging technique called endomicroscopy, which can detect cellular changes indicating pre-cancerous or cancerous growths. The system can also be used to monitor patients for recurrent disease after GERD anti-reflux surgery.

Producers of cyclotron and PET generator technologies ABT Molecular Imaging announced Oct. 20 that the company would be expanding into global markets with a $15 million boost in financing.

Toxins produced by highly specialized stem cells work to treat brain cancer. Researchers from Harvard Medical School are the engineers behind these killer stem cells.

Toshiba is bringing what is being called the industry’s largest-bore PET/CT to the upcoming Radiological Society of North America (RSNA) annual meeting next month in Chicago from Nov. 30-Dec. 5, according to an Oct. 27 announcement.

Eli Lilly and Company, makers of amyloid PET agent Amyvid, announced yesterday evening that the judge in the case of Terrence Allen, et al. v. Takeda Pharmaceuticals North America, Inc., et al, has ruled to reduce punitive damages for defendants Takeda and Lilly from $6 billion and $3 billion, respectively, down to $27.6 million and $9.2 million.

A relatively new MR technique that vastly improves imaging resolution is able to find the minute lung pathology associated with smoking habits—even before respiratory symptoms become a drag, according to a study published ahead of print Oct. 13 in Radiology.

Rick Gonzalez, former vice president of global operations for Spectrum Pharmaceuticals, is the new chief executive officer for Navidea Biopharmaceuticals, producers of Lymphoseek, the company announced recently.